Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: The SNAP01 (Studio neo-adjuvante portio) Italian collaborative study

Journal of Clinical Oncology

Volumn 23, Issue 18, 2005, Pages 4137-4145

  Buda, Alessandro ^a   Fossati, Roldano ^a   Colombo, Nicoletta ^a   Fei, Francesca ^a   Floriani, Irene ^a   Alletti, Desiderio Gueli ^a   Katsaros, Dionyssios ^a   Landoni, Fabio ^a   Lissoni, Andrea ^a   Malzoni, Carmine ^a   Sartori, Enrico ^a   Scollo, Paolo ^a   Torri, Valter ^a   Zola, Paolo ^a   Mangioni, Costantino ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPHENIRAMINE; CIMETIDINE; CISPLATIN; IFOSFAMIDE; MEPROBAMATE; METHYLPREDNISOLONE; PACLITAXEL; ANTINEOPLASTIC AGENT; TAXOID; TIP REGIMEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BONE MARROW APLASIA; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG FEVER; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HUMAN; KIDNEY FAILURE; LEUKOPENIA; LIVER FAILURE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SENSORY NEUROPATHY; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA; ADJUVANT THERAPY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; ITALY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; SURVIVAL; TREATMENT OUTCOME; UTERINE CERVIX TUMOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CISPLATIN; FEMALE; HUMANS; IFOSFAMIDE; ITALY; LOGISTIC MODELS; MIDDLE AGED; NEOADJUVANT THERAPY; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TAXOIDS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 23044498699     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.172     Document Type: Article

References (23)

1. National Cancer Institute: Concurrent chemoradiation for cervical cancer: Clinical announcement. NCI, Washington, DC, February 22, 1999
2. Green JA, Kirwan JM, Tierney JF, et al: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 358:781-786, 2001
3. Bonomi P, Blessing JA, Stehman FB, et al: Randomized trial of three cisplatin dose schedule in squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 3:1079-1085, 1985
4. Lara PC, Gracia-Puche JL, Pedraza V: Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma. Cancer Chemother Pharmacol 26S:36-38, 1990
5. Rose PG, Piver MS, et al: A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma. Cancer 71:2245-2249, 1993
6. Leone P, Vallejo C, Perez J, et al: Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma. Am J Clin Oncol 19:132-135, 1996
7. Omura GA, Blessing JA, Vaccarello L, et al: Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group Study. J Clin Oncol 15:165-171, 1997
8. Mc Guire WP, Blessing JA, Moore D, et al: Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol 14:792-795, 1996
9. Zanetta G, Lissoni A, Pellegrino A, et al: Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous cell cervical cancer. Ann Oncol 9:977-980, 1998
10. Zanetta G, Fei F, Mangioni C: Chemotherapy with paclitaxel, ifosfamide and cisplatin for the treatment of squamous cell cervical cancer: The experience of Monza. Semin Oncol 27:23-27, 2000 (suppl 1)
11. Colombo N, Gabriele A, Lissoni A, et al: Neoadjuvant chemotherapy (NACT) in locally advanced uterine cervical cancer (LAUCC): Correlation between pathological response and survival. Proc Am Soc Clin Oncol 17:352a, 1998 (abstr 1359)
12. FIGO Committee on Gynecologic Oncology: Staging classifications and clinical practice guidelines of gynaecologic cancers. Int J Gynaecol Obstet 70:207-312, 2000
13. Piver MS, Rutledge F, Smith JP: Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44:265-272, 1974
14. World Health Organization: WHO handbook for reporting results of cancer treatment. WHO offset publication No. 48. Geneva, Switzerland, WHO, 1979. Out-of-print publication: http//whqlibdoc.who.int/publications/9241700483.pdf
15. Makuch RW, Simon RM: Sample size requirements for comparing time-to-failure among k treatment groups. J Chron Dis 35:861-867, 1982
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
17. Parmar MKB, Machin D. Survival analysis: A practical approach. Chichester, United Kingdom, John Wiley, 1995
18. Begg C, Cho M, Eastwood s, et al: Improving the quality of reporting of randomized controlled trials: The CONSORT statement. JAMA 276:637-639, 1996
19. Moore DH: Neoadjuvant chemotherapy for cervical cancer. Expert Opin Pharmacother 4:859-867, 2003
20. Kim DS, Moon H, Kim KT, et al: Two-year survival: Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage IB and II with bulky tumor. Gynecol Oncol 33:225-230, 1989
21. Giaroli A, Sananes C, Sardi JE, et al: Lymph node metastases in carcinoma of the cervix uteri: Response to neoadjuvant chemotherapy and its impact on survival. Gynecol Oncol 39:34-39, 1990
22. Panici PB, Scambia G, Baiocchi G, et al: Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 67:372-379, 1991
23. Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration: Neoadjuvant chemotherapy locally advanced cervical cancer: A systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 39:2470-2486, 2003